Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer

Abroad (travel likely)Recruiting

Conditions

Pancreas Cancer · Locally Advanced · Locally Advanced Pancreatic Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States
Contact: Study coordinator (Michael Chuong, M.D.) · MichaelChu@baptisthealth.net · 786-596-2000

Study leads

Michael Chuong, M.D.
Principal Investigator
Miami Cancer Institute at Baptist Health, Inc.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

Pancreas Cancer · Pancreas Neoplasm · Pancreas Disease

Abroad (travel likely)Recruiting

Umeå, Sweden

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Pancreas Cancer · Metastatic Pancreatic Cancer · Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

Metastatic/Locally Advanced Non-Small-Cell Lung Cancer · Metastatic/Locally Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Villejuif, France · Bordeaux, France